Available resources and challenges for the clinical annotation of somatic variations

Area of Science:

• Genomics
• Bioinformatics
• Clinical Oncology

Background:

• Next-generation sequencing (NGS) is vital for identifying clinically relevant genetic variants in inherited diseases and cancer.
• Variant annotation relies on diverse public databases, including those for germline variants.
• Analyzing tumor specimens requires specialized resources for somatic variants and actionable mutations.

Purpose of the Study:

• To review the current landscape of somatic variation databases for clinical oncology.
• To discuss the interpretation of NGS-based assays in cancer using these databases.
• To highlight the need for integrated annotation solutions.

Main Methods:

• Literature review of existing somatic variation databases.
• Analysis of current practices in clinical variant annotation for oncology.
• Discussion of challenges and future directions in database integration.

Main Results:

• Numerous databases exist for germline variants, but specialized resources are needed for somatic variants in cancer.
• Somatic variation databases aid in identifying actionable mutations with clinical and treatment implications.
• Current annotation processes often involve multiple disparate resources.

Conclusions:

• Somatic variation databases are essential for the clinical interpretation of NGS in oncology.
• There is a growing need for consolidated, "one-stop" annotation solutions.
• Improved integration of databases into laboratory information systems is necessary for efficient clinical workflows.